SUBSEQUENT EVENTS (Details Narrative) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Oct. 23, 2020	Sep. 30, 2020
Yunfeng Capital Limited [Member]
Debt instrument principal amount	$ 10
Interest rate	600.00%	600.00%
Debt instrument conversion descriptions	The Company is required to repay all unpaid principal of the Yunfeng Bridge Loan 2, together with the accrued but unpaid interest thereon, on the maturity date, which is the earlier of (i) August 7, 2021, and (ii) the occurrence of an event of default (as specified in the convertible promissory note issued pursuant to the terms of the Yunfeng Bridge Loan Agreement 2 (the “Yunfeng Note 2”)), unless any such event of default has been remedied by the end of the applicable grace period.
Yunfeng Bridge Loan 2 [Member]
Debt instrument conversion descriptions	(i) on the close of business on the maturity date at a conversion price equal to the lower of (A) $19.50 per share and (B) an amount representing a 15% discount to the volume weighted average price over the preceding 30 trading days prior to and including the maturity date, subject to ratable adjustment for any stock split, stock dividend, stock combination or other recapitalization occurring subsequent to the date of the Yunfeng Note 2 or (ii) immediately prior to (but subject to) the closing of certain acquisitions of the Company (including the Merger) prior to the maturity date, at a conversion price equal to the price per share of common stock payable (or deemed payable) in such acquisition.
Proceeds of received of payement	$ 10
TF Bridge Loan Agreement [Member]
Debt instrument principal amount	$ 10
Interest rate	600.00%
Debt instrument conversion descriptions	(i) on the close of business on the maturity date at a conversion price equal to the lower of (A) $19.50 per share and (B) an amount representing a 15% discount to the volume weighted average price over the preceding 30 trading days prior to and including the maturity date, subject to ratable adjustment for any stock split, stock dividend, stock combination or other recapitalization occurring subsequent to the date of the TF Note or (ii) immediately prior to (but subject to) the closing of certain acquisitions of the Company (including the Merger) prior to the maturity date, at a conversion price equal to the price per share of common stock payable (or deemed payable) in such acquisition.
Proceeds of received of payement	$ 10

Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.

Cellular Biomedicine Group, Inc. 10-Q